Epacria Capital Partners’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-18,440
Closed -$574K 41
2025
Q1
$574K Sell
18,440
-750
-4% -$23.3K 0.47% 31
2024
Q4
$490K Hold
19,190
0.41% 36
2024
Q3
$543K Buy
19,190
+4,026
+27% +$114K 0.37% 43
2024
Q2
$400K Buy
+15,164
New +$400K 0.29% 45